Mesenchymal stem cells as a treatment strategy for coronavirus disease 2019 (COVID-19): need for authority regulations and clinical guidelines

AC Tufan - Current stem cell research & therapy, 2021 - ingentaconnect.com
The cause of Coronavirus Disease 2019 (COVID-19) known as the Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2, formerly designated 2019-nCoV) was …
被引用次数：8 相关文章 所有 4 个版本
[HTML] nih.gov

[HTML][HTML] Stem cell therapy: A promising treatment for COVID-19

ZX Zheng - World Journal of Clinical Cases, 2021 - ncbi.nlm.nih.gov
Abstract Novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic. SARS-CoV-2 is an …
被引用次数：3 相关文章 所有 5 个版本
[HTML] nih.gov

[HTML][HTML] Mesenchymal stem cells in the treatment of new coronavirus pandemic: a novel promising therapeutic approach

S Razi, Z Molavi, SA Mirmotalebisohi… - Advanced …, 2022 - ncbi.nlm.nih.gov
After severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome
(MERS) outbreaks, coronavirus disease 2019 (COVID-19) is the third coronavirus epidemic …
被引用次数：7 相关文章 所有 15 个版本
[PDF] springer.com

Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19

S Yasamineh, HG Kalajahi, P Yasamineh… - Stem Cell Research & …, 2022 - Springer
The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19
disease. Nearly 507 million individuals have been infected with this virus, with …
被引用次数：35 相关文章 所有 14 个版本

Research progress of mesenchymal stem cell therapy for severe COVID-19

Q Cai, F Yin, L Hao, W Jiang - Stem Cells and Development, 2021 - liebertpub.com
Corona virus disease 2019 (COVID-19) refers to a type of pneumonia caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Sixty million confirmed …
被引用次数：4 相关文章 所有 4 个版本
[PDF] researchgate.net

Mesenchymal stem cell-based therapy for COVID-19: possibility and potential

J Xiong, L Bao, H Qi, Z Feng… - Current Stem Cell …, 2021 - ingentaconnect.com
A novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has emerged in Wuhan, China since the end of December 2019 and has quickly spread …
被引用次数：7 相关文章 所有 5 个版本
[HTML] thelancet.comFull View

[HTML][HTML] Mesenchymal stem cell treatment for COVID-19

R Xu, Z Feng, FS Wang - EBioMedicine, 2022 - thelancet.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused a
global pandemic since late 2019 that resulted in more than 360 million population infection …
被引用次数：49 相关文章 所有 8 个版本
[PDF] sagepub.comFull View

Mesenchymal stem cell research progress for the treatment of COVID-19

D Yao, H Ye, Z Huo, L Wu… - Journal of International …, 2020 - journals.sagepub.com
At the end of 2019, novel coronavirus (COVID-19) infection was detected in Wuhan City,
Hubei Province, China. The COVID-19 infection characteristics include a long incubation …
被引用次数：7 相关文章 所有 6 个版本
[HTML] nih.gov

Feasibility of mesenchymal stem cell therapy for COVID-19: a mini review

J Li, X Wang, N Li, Y Jiang, H Huang… - Current Gene …, 2020 - ingentaconnect.com
Patients infected with SARS-CoV-2 carry the coronavirus disease 2019 (COVID-19) which
involves multiple systems and organs with acute respiratory distress syndrome (ARDS) as …
被引用次数：15 相关文章 所有 6 个版本
[PDF] springer.com

Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives

W Yao, L Shi, Y Zhang, H Dong, Y Zhang - Stem Cell Research & Therapy, 2022 - Springer
Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread into more than 200 countries …
被引用次数：27 相关文章 所有 14 个版本